Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

Abroad (travel likely)Recruiting

Conditions

Hepato Cellular Carcinoma (HCC) · Intrahepatic Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University hospital of Amiens, Amiens, France
Contact: Study coordinator (Thierry YZET, Dr) · Yzet.Thierry@chu-amiens.fr · +33(0)32 208 7536
Contact: Study coordinator (Eric NGUYEN-KHAC, Pr) · nguyen-khac.eric@chu-amiens.fr · +33(0)32 208 8851
Contact: Principal Investigator (Thierry YZET, Pr)
University hospital of Angers, Angers, France
Contact: Study coordinator (Christophe AUBE, Pr) · chaube@chu-angers.fr · +33(0)24 135 4281
Contact: Study coordinator (Frédéric OBERTI, Pr) · FrOberti@chu-angers.fr · +33(0)24 135 4670
Contact: Principal Investigator (Christophe AUBE, Pr)
University hospital of Besançon, Besançon, France
Contact: Study coordinator (Paul CALAME, Dr) · calame.paul@gmail.com · +33(0)38 166 8244
Contact: Study coordinator (Carine RICHOU, Dr) · crichou@chu-besancon.fr · +33(0)38 166 8020
Contact: Principal Investigator (Paul CALAME, Dr)
Hospital of Avicennes (AP-HP), Bobigny, France
Contact: Study coordinator (Olivier SUTTER, Dr) · olivier.sutter@aphp.fr · +33(0)14 895 5555
Contact: Study coordinator (Nathalie GANNE, Pr) · nathalie.ganne@aphp.fr · +33(0)14 802 6280
Contact: Principal Investigator (Olivier SUTTER, Dr)
University hospital of Brest, Brest, France
Contact: Study coordinator (Jean-Romain RISSON, Dr) · jean-romain.risson@chu-brest.fr · +33(0)29 834 7476
Contact: Study coordinator (Florence TANNE, Dr) · florence.tanne@chu-brest.fr · +33(0)29 814 5216
Contact: Principal Investigator (Jean-Romain RISSON, Dr)
Hospital of Beaujon (AP-HP), Clichy, France
Contact: Study coordinator (Jules GREGORY, Dr) · jules.gregory@aphp.fr · +33(0)14 087 5344
Contact: Study coordinator (Mohamed BOUATTOUR, Dr) · mohamed.Bouattour@aphp.fr · +33(0)14 087 5614
Contact: Principal Investigator (Jules GREGORY, Dr)
Hospital of Vendée, La Roche-sur-Yon, France
Contact: Study coordinator (Nadia MOUSSA, Dr) · nadia.moussa@ght85.fr · +33(0)25 144 6049
Contact: Study coordinator (Paul GIROT, Dr) · paul.girot@ght85.fr · +33(0)25 144 6168
Contact: Principal Investigator (Nadia MOUSSA, Dr)
University hospital of Grenoble-Alpes, La Tronche, France
Contact: Study coordinator (Julien GHELFI, Dr) · jghelfi@chu-grenoble.fr · +33(0)47 676 7575
Contact: Study coordinator (Thomas DECAENS, Pr) · tdecaens@chu-grenoble.fr · +33(0)47 676 6739
Contact: Principal Investigator (Julien GHELFI, Dr)
University hospital of Marseille (AP-HM), Marseille, France
Contact: Study coordinator (Farouk TRADI, Dr) · farouk.tradi@ap-hm.fr · +33(0) 413 429 083
Contact: Study coordinator (René GEROLAMI, Pr) · rene.gerolami@ap-hm.fr · +33(0) 491 388 645
Saint-Joseph Hospital, Marseille, France
Contact: Study coordinator (Xavier ADHOUTE, Dr) · xadhoute@hopital-saint-joseph.fr · +33(0) 491 808 213
University hospital of Montpellier, Montpellier, France
Contact: Study coordinator (Boris GUIU, Pr) · b-guiu@chu-montpellier.fr · +33(0)46 733 7546
Contact: Study coordinator (Georges-Philippe PAGEAUX, Pr) · gp-pageaux@chu-montpellier.fr · +33(0)46 733 7081
Contact: Principal Investigator (Boris GUIU, Pr)
University hospital of Nantes, Nantes, France
Contact: Study coordinator (Mathieu ROSTAM, Dr) · mathieu.rostam@chu-nantes.fr · +33(0)240 083 333
University hospital of Nice, Nice, France
Contact: Study coordinator (Patrick CHEVALLIER, Dr) · chevallier.p@chu-nice.fr · +33(0)49 203 6350
Contact: Study coordinator (Rodolphe ANTY, Pr) · Anty.r@chu-nice.fr · +33(0)49 203 5943
Contact: Principal Investigator (Patrick CHEVALLIER, Dr)
Saint-Antoine Hospital (AP-HP), Paris, France
Contact: Study coordinator (Lorenzo GARZELLI, Dr) · lorenzo.garzelli@aphp.fr · +33(0) 642 530 068
Contact: Study coordinator (Marie LEQUOY, Dr) · marie.lequoy@aphp.fr · +33(0) 149 283 398
Hospital of Pitié-Salpétrière (AP-HP), Paris, France
Contact: Study coordinator (Charles ROUX, Dr) · charles.roux@aphp.fr · +33(0)14 216 5545
Contact: Study coordinator (Manon ALLAIRE, Dr) · manon.allaire@aphp.fr · +33(0)62 569 6988
Contact: Principal Investigator (Charles ROUX, Dr)
Hospital of Cochin (AP-HP), Paris, France
Contact: Study coordinator (BARAT Maxime, Dr) · maxime.barat@aphp.fr · +33(0)15 841 2469
Contact: Study coordinator (POL Stanislas, Dr) · stanislas.pol@aphp.fr · +33(0)15 841 3101
Contact: Principal Investigator (Maxime BARAT, Pr)
Univesity hospital of Bordeaux, Pessac, France
Contact: Study coordinator (Panteleimon PAPADOPOULOS, Dr) · panteleimon.papadopoulos@chu-bordeaux.fr · +33(0)55 679 5679
Contact: Study coordinator (Jean-Frédéric BLANC, Pr) · jean-frederic.blanc@chu-bordeaux.fr · +33(0)55 765 6439
Contact: Principal Investigator (Panteleimon PAPADOPOULOS, Dr)
University hospital of Toulouse, Toulouse, France
Contact: Study coordinator (Fatima MOKRANE, Pr) · mokrane.fz@chu-toulouse.fr · +33(0) 561 322 851
Contact: Study coordinator (Jean-Marie PERON, Pr) · peron.jm@chu-toulouse.fr · +33(0) 561 323 414
Institut Gustave Roussy (IGR), Villejuif, France
Contact: Study coordinator (Paul BEUNON, Dr) · paul.beunon@gustaveroussy.fr · +33(0)14 211 5428
Contact: Study coordinator (Valérie BOIGE, Dr) · valerie.boige@gustaveroussy.fr · +33(0)14 211 4289
Contact: Principal Investigator (Paul BEUNON, Dr)

Study leads

Christophe AUBE, Pr
Principal Investigator
University Hospital, Angers
Jules GREGORY, Assoc Pr
Principal Investigator
Beaujon Hospital (APHP) - Paris cité University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Impact of Anaesthesia on Inflammation and NETosis in Hepatocellular Carcinoma Resection

Hepato Cellular Carcinoma (HCC) · Sedation and Analgesia · Ablation Techniques

Abroad (travel likely)Recruiting

Cluj-Napoca, Romania

Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab

Hepato Cellular Carcinoma (HCC)

Abroad (travel likely)RecruitingPHASE2

Bologna, Italy

SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

Hepato Cellular Carcinoma (HCC) · Hand Foot Skin Syndrome

Abroad (travel likely)RecruitingPHASE2

Taipei, Taiwan

PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)

Hepato Cellular Carcinoma · Cirrhosis · Autonomic Nervous System

Abroad (travel likely)Recruiting

Lyon, France